Information  X 
Enter a valid email address

Feedback PLC (FDBK)

  Print          Annual reports

Thursday 05 November, 2020

Feedback PLC

Bleepa selected for WISH 2020 Innovation Awards

RNS Number : 3026E
Feedback PLC
05 November 2020


Feedback plc


Bleepa selected for WISH 2020 Innovation Awards Programme


· World Innovation Summit for Health ("WISH") - 15-19 November 2020

· Named as a WISH 2020 Innovation Booster

· Year-long prestigious awards programme enables access to key Middle-East healthcare markets


London, 5 November 2020: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces that Bleepa has been selected as a WISH 2020 Innovation Booster at the World Innovation Summit for Health, 15-19 November 2020 in Doha, Qatar.


The WISH 2020 Innovation Booster


The WISH Innovation Booster provides a chance for entrepreneurs to exhibit their healthcare innovations in front of some of the world's leading health experts, health ministers, decision-makers, and investors. WISH provides a platform to enable delegates to engage with these cutting-edge ideas that are changing healthcare from the ground up.


The WISH 2020 Innovation Booster programme represents some of the world's most exciting healthcare innovations, ranging from practical devices and business models to design-based solutions. Companies showcasing their innovations share a common goal: driving improvement and excellence in healthcare. Each innovation showcase has the potential to transform global health, both reducing the costs of healthcare delivery and improving the quality of care for patients.


Dr Tom Oakley, CEO of Feedback, commented:


"We are delighted to have been accepted for the prestigious virtual WISH programme which is a dedicated showcasing event into the Middle-Eastern healthcare markets.  Every year, WISH selects a handful of products from around the world that it really wants to champion and promote, and it awards them a WISH fellowship, providing a year-long dedicated programme of support to launch those products into the Middle-Eastern market and we are proud to say that Bleepa has been chosen as one of their WISH 2020 Innovation Boosters.  This represents a fantastic opportunity for us to really promote Bleepa into the Middle-East." 






Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

[email protected]



Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

+44 (0)20 3328 5656



Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey

+44 (0)20 7469 0936



Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

+44 20 3815 8880



Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected]

Paul McManus/Nick Rome/Nicholas Johnson

07980 541 893 or 07748 325 236 or 07884 664 686



Notes to Editors


Feedback plc (AIM: FDBK) is a medical imaging technology business. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go. 


Its highly scalable Software as a Service ("SaaS")-based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care facilitators. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of diagnosis.


About WISH


We forge connections and help build action-driven communities of knowledge who work together to address today's most pressing global healthcare challenges.


We convene and collaborate with the world's leading experts and the highest levels of decision-makers.


We create and disseminate world-class, evidence-based content and knowledge.


We promote active learning and support within and between communities.


We contribute to the vision and mission of Qatar Foundation for Education, Science and Community Development and Qatar National Vision 2030, and serve to underscore Qatar's pioneering role as an emerging center for healthcare innovation.


We showcase innovations that will make a difference for healthcare communities everywhere.


We aim to influence healthcare policy globally.


About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.


This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t